Treatment News : Vitamin D Deficiencies Linked to Diabetes in People With HIV

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » January 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


January 5, 2011

Vitamin D Deficiencies Linked to Diabetes in People With HIV

HIV-positive people with vitamin D deficiency were far more likely to also have type 2 diabetes than people who were not vitamin D deficient, according to a study published online December 20 in the journal AIDS.

Poor vitamin D levels in people with HIV have become a prominent concern among AIDS researchers in recent years. Vitamin D deficiency has been linked to a number of health conditions in HIV-negative people, including: poor bone strength and density, type 2 diabetes, metabolic syndrome and cardiovascular disease (CVD).

A number of recent studies have also consistently found that vitamin D levels are deficient in a significant number of people living with HIV in the Northern Hemisphere. What remains unclear, however, is whether HIV and its treatment are solely responsible for the increase in diseases such as diabetes and CVD seen in HIV-positive people, or whether low vitamin D levels also contribute in a meaningful way.

To begin answering these questions, Zsofia Szep, MD, from the University of Pennsylvania Medical School in Philadelphia, and her colleagues tested vitamin D levels in participants enrolled in the Modena HIV Metabolic Clinic Cohort in Italy. Their aim was to determine whether vitamin D deficiency was linked to either type 2 diabetes or metabolic syndrome. Metabolic syndrome involves having a large waist circumference and problems with cholesterol and triglycerides and blood sugar control, and it is a significant risk factor for diabetes, heart attacks and strokes.

Among the 1,405 participants in the study, most were male and the average age was 44. About 45 percent were also infected with hepatitis C virus (HCV), but few were taking vitamin D supplements.

Overall, Szep and her colleagues found that 62 percent of the study participants had vitamin D deficiency—defined as blood levels of 25-hydroxyvitamin D less than 20 nanograms per milliliter (ng/ml). An additional 20 percent had vitamin D insufficiency—blood levels of vitamin D of at least 20 ng/ml but less than 30 ng/ml.

When Szep’s team accounted for a number of factors that can contribute to type 2 diabetes—such as sex, age, body mass index and HCV coinfection—vitamin D deficiency remained strongly associated with type 2 diabetes. In fact, vitamin D deficiency predicted the presence of type 2 diabetes more than any other factor, and people with vitamin D deficiency were 85 percent more likely to have diabetes than people who weren’t deficient.

As far as metabolic syndrome, there was a trend toward association—people with vitamin D deficiency were 32 percent more likely to have metabolic syndrome—but this did not reach statistical significance. This means that the difference was small enough that it could have occurred by chance.

The authors acknowledge that the study design, which involved a snapshot of people’s health at a single point in time, can’t establish whether vitamin D deficiency causes diabetes or whether the link is coincidental. However, they note that maintaining good vitamin D levels is associated with reducing blood vessel inflammation in HIV-negative people. Given that HIV itself significantly increases inflammation—a precursor to diabetes and CVD—it is possible that HIV levels and vitamin D levels are synergistically contributing to these health problems.

“Future studies should examine whether vitamin D supplementation can prevent or treat type 2 diabetes mellitus in HIV and possibly reduce complications associated with HIV infection and its treatment,” the authors conclude.

Search: Vitamin D, diabetes, metabolic syndrome, cardiovascular disease, CVD, Zsofia Szep

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.